Fig. 1From: A novel intergenic region (chr2: 30,193,816)-ALK fusion shows sensitivity to Alectinib in lung adenocarcinomaA Tracheoscopy revealing neoplasm in the medial segment of the middle lobe of the right lung; B IHC analysis indicated the sample being positive for Napsin A, TTF-1, CK7 and ALK, suggesting a primary lung adenocarcinoma (× 400). C Radiological features before and after Alectinib treatmentBack to article page